Stay updated on Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.

Latest updates to the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, reflecting a new version of the page.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2. This indicates a newer version of the page was published, without changes to the study details.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page now shows that recruitment is no longer ongoing. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was reformatted, with a new Revision: v3.6.0 note.SummaryDifference0.5%

- Check36 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor template/deployment update rather than a change to the page's content or purpose.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a behind-the-scenes update to the site’s infrastructure or publishing workflow. No visible changes to the study information or layout are introduced.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a platform-level update to the page rendering. The study details and patient-focused information remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.